Boost for Covaxin: After WHO nod, Lancet study says vaccine 77.8% effective | Hindustan Times
close_game
close_game

Boost for Covaxin: After WHO nod, Lancet study says vaccine 77.8% effective

India’s indigenous Covid-19 vaccine Covaxin offers 77.8% protection against symptomatic cases, as per data released in the Lancet. Hyderabad-based Bharat Biotech’s Covid-19 vaccine Covaxin is among the vaccines used in India for inoculation. The vaccine recently got WHO nod for emergency use. The data in Lancet said Covaxin is 77.8% effective against symptomatic Covid-19 cases and 93.4% efficacy against severe symptomatic Covid cases. Watch the full video for more details. 

 
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, May 25, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On